glp-1 drugs and anesthesia American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients on Glucagon-Like Peptide-1 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations
Description
And when progress slows, patients look elsewhere
Tirzepatide was more efficacious in reducing body weight
A key feature of the consensus is its endorsement of shared decision-making, taking into account patient goals, preferences, access, and affordability
President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatm
Discover cost-effective, personalized weight loss solutions
Trulicity vs Zepbound: Zepbound delivers 21% weight loss vs Trulicity's 4-7% with dual GIP/GLP-1 action
